<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">1580592</PMID>
      <DateCompleted>
        <Year>1992</Year>
        <Month>06</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2013</Year>
        <Month>11</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0066-4219</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>43</Volume>
            <PubDate>
              <Year>1992</Year>
            </PubDate>
          </JournalIssue>
          <Title>Annual review of medicine</Title>
          <ISOAbbreviation>Annu Rev Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Chlamydia pneumoniae, strain TWAR pneumonia.</ArticleTitle>
        <Pagination>
          <StartPage>317</StartPage>
          <EndPage>323</EndPage>
          <MedlinePgn>317-23</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Chlamydia pneumoniae, strain TWAR is a newly recognized third species of Chlamydia. It is an important cause of pneumonia, bronchitis, sinusitis, and other acute respiratory infections. It is a human pathogen transmitted by the respiratory route. Successful antibiotic treatment with tetracycline or erythromycin requires high dosage and a prolonged course.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Grayston</LastName>
            <ForeName>J T</ForeName>
            <Initials>JT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology, University of Washington, Seattle 98195.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Annu Rev Med</MedlineTA>
        <NlmUniqueID>2985151R</NlmUniqueID>
        <ISSNLinking>0066-4219</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>63937KV33D</RegistryNumber>
          <NameOfSubstance UI="D004917">Erythromycin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>F8VB5M810T</RegistryNumber>
          <NameOfSubstance UI="D013752">Tetracycline</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002690" MajorTopicYN="N">Chlamydia Infections</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016993" MajorTopicYN="N">Chlamydophila pneumoniae</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004917" MajorTopicYN="N">Erythromycin</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013752" MajorTopicYN="N">Tetracycline</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <NumberOfReferences>5</NumberOfReferences>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1992</Year>
          <Month>1</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1992</Year>
          <Month>1</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1992</Year>
          <Month>1</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">1580592</ArticleId>
        <ArticleId IdType="doi">10.1146/annurev.me.43.020192.001533</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
